At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14,141 enrolled
Drug / intervention
Amlodipinedrug
Likely dose
Amlodipine 5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NORVASC10MG DRUG USE INVESTIGATION
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·observational·Posted Dec 3, 2010·Updated Jan 28, 2021
In Brief
An observational study evaluating Amlodipine for Hypertension. Completed, enrolled 14,141 participants.
Detailed Summary
In this survey, to collect the safety and efficacy information in the subjects who have been treated with amlodipine 5mg at least 4 weeks in daily practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2010
First PostedDec 2010
Primary CompletionOct 2012
TodayJul 2026
First PostedDec 3, 2010
Enrollment StartDec 1, 2010
Primary CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.6 years ago
Interventions
Amlodipinedrug
Usual adult dosage is 2.5-5 mg of amlodipine given orally as a single daily dose. Dosage should be adjusted depending on the patient's symptoms. The dose can be raised up to 10 mg once daily for patients who show inadequate response.